Literature DB >> 7669772

Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity.

M A Clay1, G M Anantharamaiah, M J Mistry, A Balasubramaniam, J A Harmony.   

Abstract

Apoliprotein E (apoE) is a potent suppressor of interleukin 2- (IL2-) dependent T lymphocyte proliferation. In this study, we have used a range of monomeric and dimeric peptides encompassing amino acids 130-169 in human apoE to locate a region with both cytostatic and cytotoxic effects on IL2-dependent T lymphocytes. Monomeric peptides representing residues 130-149 or 130-155 inhibited the proliferation of the cells without causing loss of cell viability. However, cytostasis by a peptide representing the extended 130-169 domain or dimeric peptides of amino acids 141-155 or 141-149 was accompanied by potent cytotoxic activity. These results suggest that residues 141-149, which include the overlap between the functional peptides, are responsible for cytostasis and cytotoxicity. Complete ablation of both activities by the polyanionic agent heparin highlighted the important contribution of the positively charged amino acids in the 141-149 region to peptide bioactivity. Furthermore, the bioactive apoE peptides also had a relatively high helical content, suggesting that alpha-helical content is necessary for bioactivity. Cytotoxic apoE peptides were characterized by a high density of polar face positively charged residues together with a high nonpolar face hydrophobicity. This conclusion is supported by the reduced hydrophobicity and polar face positive charge density of the significantly less active E2(130-169) peptide. The cytotoxic apoE peptides are structurally similar to previously characterized class L lytic peptides. They do not, however, exert their cytotoxic activity by destabilizing membrane bilayers as is the case with the class L peptides, as evidenced by their minimal hemolytic activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669772     DOI: 10.1021/bi00035a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 3.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

Review 4.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

5.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

6.  Anti-infective activity of apolipoprotein domain derived peptides in vitro: identification of novel antimicrobial peptides related to apolipoprotein B with anti-HIV activity.

Authors:  Bridie A Kelly; Ian Harrison; Aine McKnight; Curtis B Dobson
Journal:  BMC Immunol       Date:  2010-03-18       Impact factor: 3.615

Review 7.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein.

Authors:  Zhenyu Sheng; Mary Prorok; Brigid E Brown; Francis J Castellino
Journal:  Neuropharmacology       Date:  2008-05-24       Impact factor: 5.250

10.  A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.

Authors:  Ling Guo; Mary Jo LaDu; Linda J Van Eldik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.